Steve Jobs’s Son Gets Into Venture Capital


Reed Jobs, 31, is starting an investment firm to focus on new cancer treatments, continuing a yearslong focus on a disease that hits close to home.


By Andrew Ross Sorkin, Ravi Mattu, Sarah Kessler, Michael J. de la Merced, Lauren Hirsch and Ephrat Livni | NYTimes | NYT > Business | Disclosure

Comments